Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men

American Journal of Epidemiology

Volumn 143, Issue 9, 1996, Pages 889-897

  Haffner, Steven M ^a   Shaten, Jessica ^b,e   Stern, Michael P ^a   Smith, George Davey ^c   Kuller, Lewis ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

diabetes mellitus; insulin; prasterone; sex hormone binding globulin; testosterone

Indexed keywords

GLUCOSE; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

EID: 0029874336     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008832     Document Type: Article

References (40)

1. Ohlson LO, Larsson B, Svärdsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985;34:1055-8.
2. Sicree RA, Zimmet PZ, King HOM, et al. Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 yr. Diabetes 1987;36:179-86.
3. Haffner SM, Stern MP, Mitchell BD, et al. Incidence of type II diabetes by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes 1990;39:283-8.
4. Saad MF, Knowler WC, Pettitt DJ, et al. The natural history of impaired glucose tolerance in Pima Indians. N Engl J Med 1988;319:1500-6.
5. Lundgren H, Bengtsson C, Blohme G, et al. Adiposity and adipose tissue distribution in relation to the incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes 1989;13:413-23.
6. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993;329:1988-92.
7. Woodard TL, Burghen GA, Kitbachi AE, et al. Glucose intolerance and insulin resistance in aplastic anemia treated with oxymethalone. J Clin Endocrinol Metab 1981;53:905-8.
8. Phillips GB. Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci U S A 1977;74:1729-33.
9. Lichtenstein MJ, Yamell YWG, Elwood PC, et al. Sex hormones, insulin, Iipids, and prevalent ischemic heart disease. Am J Epidemiol 1987;126:647-57.
10. Seidell JC, Björntorp P, Sjöström L, et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990;39:897-901.
11. Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991;40:101-4.
12. Simon D, Preziosi P, Barrett-Connor E, et al. Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 1992;35:173-7.
13. Phillips G. Relationship between sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 1993;42:116-20.
14. Haffner SM, Valdez RA, Mykkänen L, et al. Decreased free testosterone and dehydroepiandrosterone sulfate are associated with decreased glucose and insulin concentrations in non-diabetic men. Metabolism 1994;43:599-603.
15. Haffner SM, Karhapää P, Mykkänen L, et al. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 1994;43:212-19.
16. Small M, MacRury S, Beastall GH, et al. Oestradiol levels in diabetic men with and without a previous myocardial infarction. Q J Med 1987;64:617-23.
17. Barrett-Connor E. Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 1992;117:807-11.
18. Barrett-Connor E, Khaw KT, Yen SSC. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 1990;132:895-901.
19. Cohen JC, Hickman R. Insulin resistance and diminished glucose tolerance in power lifters ingesting anabolic steroids. J Clin Endocrinol Metab 1987;64:960-3.
20. Friedel KG, Jones RE, Hannan CJ, et al. The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance. J Clin Endocrinol Metab 1989; 68:971-5.
21. Anderson DC. Sex hormone binding globulin. Clin Endocrinol (Oxf) 1974;3:69-96.
22. Haffner SM, Valdez RA, Morales PA, et al. Decreased sex hormone binding globulin predicts non-insulin dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 1993;77:56-60.
23. Sherwin R, Kaelber CT, Kezdi P, et al. The Multiple Risk Factor Intervention Trial (MRFIT). II. The development of the protocol. Prev Med 1981;10:402-25.
24. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982;248:1465-77.
25. Multiple Risk Factor Intervention Trial Group. Statistical design considerations in the NHLJ Multiple Risk Factor Intervention Trial (MRFIT). J Chronic Dis 1977;30:261-75.
26. Widdowson GM, Kuehneman M, DuChene AG, et al. Quality control of biochemical data in the Multiple Risk Factor Intervention Trial: Central Laboratory. Control Clin Trials 1986; 7(3 Suppl):17S-33S.
27. Roberts J. National Center for Health Statistics: weight by height and age of adults. United States, 1960-62. Washington, DC: US GPO, 1966. (Vital and health statistics, Series II, no. 14) (PHS publication no. 1000).
28. Shaten BJ, Smith GD, Kuller LH, et al. Risk factors for the development of type II diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:1331-9.
29. Herbert V, Lauk S, Gottlieb CW. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965;25:1375-84.
30. Orchard TJ, Eichner J, Kuller LH, et al. Insulin as a predictor of coronary heart disease: interaction with apo E phenotype. A report from MRHT. Ann Epidemiol 1994;4:53-8.
31. Holmäng A, Bjömtorp P. The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand 1992;146:505-10.
32. Mårin P, Holmäng S, Jönsson L, et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes 1992;16:991-7.
33. Plymate SR, Matej LA, Jones RE, et al. Inhibition of sex-hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988;67:460-4.
34. Nestler JE, Strauss JF. Insulin as an effector of human and ovarian adrenal metabolism. Endocrinol Metab Clin North Am 1991;20:807-23.
35. Nestler JE. Sex hormone binding globulin: a marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab 1993;76:273-4.
36. Birkeland KI, Haussen KF, Torjesan PA, et al. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 1993;76:275-8.
37. Peins AN, Stagner JI, Plymate SR, et al. Relationship of insulin secretory pulses to sex-hormone-binding globulin in normal men. J Clin Endocrinol Metab 1993;76:279-82.
38. Eriksson J, Fransilla-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 1989;321:337-43.
39. Gulli G, Ferrannini E, Stern MP, et al. The metabolic profile of non-insulin dependent diabetes mellitus is fully established in glucose tolerant offspring of two Mexican-American parents. Diabetes 1992;41:1575-86.
40. Hollenbeck CB, Chen N, Chen YDI, et al. Relationship between plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984;33:460-3.